NCT04097067
- Conditions
- Follicular Lymphoma (Gastric or Duodenal), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Department of Radiation Oncology Münster, North Rhine-Westphalia, Germany
Clinical trial condition
Lymphoma, B-Cell, Marginal Zone
Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.
645 public trials
88 recruiting studies
Lymphoma, B-Cell, Marginal Zone trial results
NCT06566807
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University#Huai'an First People's Hospital# Huai'an, Jiangsu, China
NCT06478472
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Bing, Xu Xiamen, Fujian, China
NCT06513234
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- China Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China
NCT06454968
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06134284
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The Second Affiliated Hospital of Zhejiang University, Ningbo First Hospital Hangzhou, Zhejiang, China
- 86-574-87085596 Ningbo, Zhejiang, China
- The First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China
Recruiting
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma
NCT05846750
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tian, China
NCT03869619
- Conditions
- Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
- Locations
-
- Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
- Service d'Hématologie, CHU Jean Minjoz Besançon, France
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Institut Bergonié Bordeaux, France
Enrolling by Invitation
Watch and Wait or Worry and Wait in Indolent Lymphoma
NCT07173790
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
- Locations
-
- Samsung Medical Center Seoul, Gangnam-gu, South Korea
- Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea
- Seoul National University Hospital Seoul, Jongno-gu, South Korea
- The Catholic University of Korea Seoul, Seocho-gu, South Korea
Enrolling by Invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
NCT07168486
- Conditions
- B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
- Locations
-
- University of Maryland, Baltimore Baltimore, Maryland, United States